Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuraLight has developed an AI-powered software platform that uses computer vision to analyze eye movements from video to generate objective digital biomarkers for central nervous system diseases. The technology enables more sensitive and objective measurement of neurological function than traditional methods. It has been validated in multiple peer-reviewed studies and integrated into several ongoing clinical trials for neurodegenerative conditions such as ALS, Parkinson's disease, MS, and Alzheimer's disease. The company partners with leading medical centers worldwide to support drug development by providing novel endpoints for patient stratification and monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuraLight.